TL;DR
Get health and wellness essentials delivered free with Prime
- Fast, free delivery on millions of items
- Prime Video, Amazon Music and more included
- Member-only deals all year
A post hoc analysis of a randomized trial found that older adults assigned to eat walnuts had about 6% higher total IgG after two years than those assigned to avoid walnuts. The study did not establish that this difference improves immune function or prevents cardiovascular disease, and it found no significant walnut-related changes in several other immune markers.
A post hoc analysis of the Walnuts and Healthy Aging (WAHA) trial, published in November 2026, found that older adults assigned to eat walnuts had about 6% higher total serum IgG than participants assigned to avoid walnuts after two years. The result suggests a possible effect on an immune-system biomarker, but the researchers did not show that the difference improves health or reduces cardiovascular risk.
The analysis drew on the Walnuts and Healthy Aging (WAHA) trial, which enrolled 708 cognitively healthy adults aged 63 to 79 in the United States and Spain. As described in the WAHA trial report, participants were assigned to a walnut-based or walnut-excluding diet for two years. The walnut group was asked to eat 30 to 60 grams daily, roughly 15% of daily energy intake.
For this later analysis, the researchers measured immune-related markers in stored blood samples from 474 participants: 240 in the walnut group and 234 controls. The analysis report says these included total IgG and IgM, antibodies directed at MDA-modified LDL, and circulating MDA-LDL. The original WAHA trial focused on cognitive function and retinal integrity, rather than these immune outcomes.
According to the analysis, after accounting for baseline measurements and factors including age, sex, smoking, cholesterol, body mass index, hypertension and diabetes, total IgG was about 6% higher overall in the walnut group. The difference was 11% among US participants; the researchers found no statistically significant intervention effect in Spain. Walnut assignment did not significantly affect total IgM, MDA-LDL concentrations, or either class of MDA-LDL-specific antibody.
What the IgG Difference Can Tell Us
IgG is a major class of antibody, and total serum IgG is one measure of circulating humoral immunity. But a higher total level is not, by itself, evidence of stronger protection against infection or better overall health. The WAHA analysis measured a biomarker; it did not test whether participants experienced fewer illnesses, improved immune responses, or fewer cardiovascular events as a result of eating walnuts.
The analysis report discusses the relevance of studying immune activity in relation to atherosclerosis, the buildup of plaque in arteries. Oxidized forms of LDL can prompt immune responses, and prior studies cited by the researchers have linked particular antibodies or total IgG with cardiovascular measures. Those associations do not establish that raising IgG through diet prevents heart disease. The WAHA analysis found no significant effect on the MDA-LDL-specific antibodies it measured, leaving the proposed connection to vascular health unresolved.
Products Worth Considering
Oura Ring 5 Smart Ring, Silver, Size 7
Philips Sonicare 5950 Rechargeable Electric Toothbrush with 2 Brush Heads, Pink
Levoit Core 400S-P Smart Air Purifier for Large Rooms
As an affiliate, we earn on qualifying purchases.
How the WAHA Analysis Was Done
The WAHA trial report says participants were enrolled between May 2012 and May 2014 and followed for two years. People who already ate more than two servings of tree nuts weekly, among others meeting specified exclusion criteria, were not included. The study monitored participants periodically for weight, tolerance, diet adherence and medication use.
The immune-marker analysis was post hoc: it examined outcomes that were not the original trial’s main focus. According to the analysis report, researchers used blood samples collected at the start and after two years, and adjusted their comparisons for several health and demographic factors. The report also notes meaningful differences between the Spanish and US groups at baseline, including lower average total IgG and IgM in US participants. In Spain, red blood cell alpha-linolenic acid levels rose substantially in the walnut group and fell in controls, which the researchers used as evidence of dietary adherence.
The analysis reported that across both diet groups, total IgG, total IgM and MDA-LDL-specific IgM declined over the two years; MDA-LDL-specific IgG did not. These changes within groups are separate from the comparison between walnut and control participants. The adjusted between-group result was limited to total IgG.
What the Results Do Not Show
The analysis report does not establish why total IgG was higher in the walnut group, whether the difference is meaningful to a person’s health, or whether it persists beyond two years. It also does not show that walnuts treat immune problems or prevent atherosclerosis. The difference was not statistically significant in the Spanish participants, and the report does not establish why the findings differed by study center.
Because the analysis examined selected biomarkers in a subset of the original trial participants, its findings should be interpreted as a signal for further research, not proof of a clinical benefit. The reported results do not provide evidence that changing IgG levels should guide individual dietary or medical decisions.
What Researchers Need to Test
Further studies would need to determine whether the IgG difference can be replicated, explain the variation between study centers, and connect any biomarker change to outcomes that matter to patients, such as cardiovascular events or clinically relevant immune measures. The available analysis report does not specify a follow-up study or a publication timetable for additional results.
For now, the finding adds to research on diet and immune biomarkers but does not change what can be concluded about walnuts and disease prevention. Readers considering changes to their diet for a health condition should discuss them with a qualified health professional.
Key Questions
What did the study find about walnuts and IgG?
In a post hoc analysis of the WAHA trial, participants assigned to eat 30 to 60 grams of walnuts daily had about 6% higher total IgG after two years than controls, after statistical adjustment. The analysis report found an 11% difference among US participants, while researchers did not detect a statistically significant effect in Spain.
Does higher IgG mean a stronger immune system?
Not necessarily. Total IgG is an antibody measure, but the WAHA analysis did not show that a higher level improved protection from infection or another health outcome. The meaning of the observed difference remains uncertain.
Did walnuts change the other immune markers?
The analysis report found no significant walnut-related effect on total IgM, circulating MDA-LDL, or antibodies specifically targeting MDA-LDL. Those markers therefore did not show the same between-group result as total IgG.
Does this prove walnuts prevent heart disease?
No. The WAHA analysis measured blood biomarkers, not whether walnut consumption prevented cardiovascular events. Its findings do not establish that walnuts lower an individual’s risk of atherosclerosis or heart disease.
Source: news-medical.net
